These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 33789746)

  • 1. Clinical features and relapse risks of IgG4-related ophthalmic disease: a single-center experience in China.
    Zhao Z; Mou D; Wang Z; Zeng Q; Wang Z; Xue J; Ren L; Liu Y; Su Y
    Arthritis Res Ther; 2021 Mar; 23(1):98. PubMed ID: 33789746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical features and relapse risks factors of IgG4 related disease: a single-center retrospective study.
    Zhang X; Zeng Z; Tian H; Wang N; Wang Y; Tong J; Chang B; Jin X; Huang D; Wang Y; Cui H; Guan L; Li Y
    Clin Exp Med; 2023 Nov; 23(7):3527-3538. PubMed ID: 37392248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salivary gland involvement disparities in clinical characteristics of IgG4-related disease: a retrospective study of 428 patients.
    Liu Y; Xue M; Wang Z; Zeng Q; Ren L; Zhang Y; Zhang S; Wang Y; Shen D; Xia C; Yu G; Li ZG
    Rheumatology (Oxford); 2020 Mar; 59(3):634-640. PubMed ID: 31436287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ophthalmic involvement disparities in clinical characteristics of IgG4-related disease: a retrospective study of 573 patients.
    Gan L; Luo X; Fei Y; Peng L; Zhou J; Li J; Lu H; Liu Z; Zhang P; Liu X; Zhang W
    BMC Ophthalmol; 2021 Dec; 21(1):447. PubMed ID: 34961492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical profiles differ in IgG4-related disease with and without allergy: a large case-control study in China.
    Zhao Z; Liu Y; Bai M; Zeng Q; Wang Z; Chen D; Li Z; Su Y
    Clin Exp Rheumatol; 2023 Sep; 41(9):1808-1814. PubMed ID: 36826798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The clinical characteristics of 346 patients with IgG
    Zhang PP; Zhao JZ; Wang M; Feng RE; Liu XW; Lai XM; Li XJ; Zeng JG; Shi HJ; Zhu HD; Xue W; Zhang H; Chen YY; Fei LY; Peng XF; Zeng FC; Zhang YM; Zhang W
    Zhonghua Nei Ke Za Zhi; 2017 Sep; 56(9):644-649. PubMed ID: 28870031
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical characteristics and outcome of IgG4-related disease with hypocomplementemia: a prospective cohort study.
    Peng L; Lu H; Zhou J; Zhang P; Li J; Liu Z; Wu D; Zhang S; Yang Y; Bai W; Wang L; Fei Y; Zhang W; Zhao Y; Zeng X; Zhang F
    Arthritis Res Ther; 2021 Apr; 23(1):102. PubMed ID: 33827676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics and therapeutic response of immunoglobulin G4-related disease: a retrospective study of 127 Chinese patients.
    An W; Wu Z; Li M; Yu H; Zhao X; Wang X; Wang Y; Wang Q; Duan W; Kong Y; Ma H; Ou X; You H; Liu Y; Li P; Duan T; Jia J
    Orphanet J Rare Dis; 2022 Aug; 17(1):307. PubMed ID: 35927746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Symptom Duration and Serologic Factors in the Relapse of IgG4-Related Ophthalmic Disease following Surgery: A Retrospective Cohort Study.
    Liu S; Yue Z; Zeng C; Huang X; Li J; Diao J; Chen X; Wei R; Yang W
    Dis Markers; 2022; 2022():5651506. PubMed ID: 35256891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IgG4-related uveitis. A French cohort and literature review.
    Stuchfield-Denby E; De Sainte Marie B; Hie M; Hatchuel Y; Gerber A; Bencheikh S; Pugnet G; Groh M; Farhat MM; Urbina D; Ebbo M; Schleinitz N
    Semin Arthritis Rheum; 2024 Feb; 64():152278. PubMed ID: 38000318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum IgE in the clinical features and disease outcomes of IgG4-related disease: a large retrospective cohort study.
    Zhou J; Peng Y; Peng L; Wu D; Li J; Jiang N; Li J; Lu H; Liu Z; Luo X; Teng F; Fei Y; Zhang W; Zhao Y; Zeng X
    Arthritis Res Ther; 2020 Oct; 22(1):255. PubMed ID: 33097076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex disparities in clinical characteristics and prognosis of immunoglobulin G4-related disease: a prospective study of 403 patients.
    Wang L; Zhang P; Zhang X; Lin W; Tang H; Li J; Wang M; Liu X; Fei Y; Chen H; Peng L; Zhang L; Lai Y; Zeng X; Li X; Xue H; Zhao Y; Zhang F; Zhang W
    Rheumatology (Oxford); 2019 May; 58(5):820-830. PubMed ID: 30561747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relapse predictors and serologically unstable condition of IgG4-related disease: a large Chinese cohort.
    Liu Y; Zeng Q; Zhu L; Gao J; Wang Z; Wang Z; Yang F; Wang K; Chen D; Xia C; Zhang S; Wang Y; Shen D; Yu G; Li ZG
    Rheumatology (Oxford); 2020 Aug; 59(8):2115-2123. PubMed ID: 32097488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-Term Outcomes of IgG4-Related Ophthalmic Disease in a Chinese IgG4-Related Disease Cohort.
    Gan L; Luo X; Fei Y; Peng L; Zhou J; Li J; Lu H; Liu Z; Zhang P; Liu X; Zhang W
    Front Med (Lausanne); 2021; 8():784520. PubMed ID: 34977087
    [No Abstract]   [Full Text] [Related]  

  • 15. Revealing the distinct clinical patterns and relapse risk factors in seronegative IgG4-RD patients: A retrospective cohort study over a decade.
    Peng Y; Wang M; Sun R; Nie Y; Zhang N; He X; Sun B; Peng L; Fei Y; Zhou J; Li M; Zhang W
    J Intern Med; 2024 Aug; 296(2):200-212. PubMed ID: 38924246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical features of IgG4-related retroperitoneal fibrosis among 407 patients with IgG4-related disease: a retrospective study.
    Liu Y; Zhu L; Wang Z; Zeng Q; Yang F; Gao J; Wang Z; Wang K; Ren L; Zhang Y; Zhang S; Wang Y; Shen D; Xia C; Yu G; Li Z
    Rheumatology (Oxford); 2021 Feb; 60(2):767-772. PubMed ID: 32793960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences and similarities between IgG4-related disease with and without dacryoadenitis and sialoadenitis: clinical manifestations and treatment efficacy.
    Wang M; Zhang P; Lin W; Fei Y; Chen H; Li J; Zhang L; Zheng W; Li Y; Zeng X; Zhou J; Lai Y; Liu X; Xue H; Cui Y; Zhou L; Zhao J; Zhang W
    Arthritis Res Ther; 2019 Feb; 21(1):44. PubMed ID: 30709411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of iguratimod on patients with relapsed or refractory IgG4-related disease.
    Liu Y; Zhang Y; Bian W; Fu J; Sun X; Chen D; Chen J; Zhao X; Li Y; Zhang W; Li Z
    Clin Rheumatol; 2020 Feb; 39(2):491-497. PubMed ID: 31848912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum IgG4 level during initial treatment as a predictor of relapse in IgG4-related disease.
    Choi SJ; Ahn SM; Oh JS; Hong S; Lee CK; Yoo B; Kim YG
    PLoS One; 2023; 18(3):e0282852. PubMed ID: 36893163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoglobulin G4-related retroperitoneal fibrosis.
    Angarola E; Valeo Chulvi M; Peuchot V; García Rivello H; Jauk F
    Medicina (B Aires); 2022; 82(1):91-98. PubMed ID: 35037866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.